1999
DOI: 10.1128/iai.67.12.6572-6582.1999
|View full text |Cite
|
Sign up to set email alerts
|

Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection

Abstract: New vaccine strategies are needed for prevention of leptospirosis, a widespread human and veterinary disease caused by invasive spirochetes belonging to the genus Leptospira. We have examined the immunoprotective capacity of the leptospiral porin OmpL1 and the leptospiral outer membrane lipoprotein LipL41 in the Golden Syrian hamster model of leptospirosis. Specialized expression plasmids were developed to facilitate expression of leptospiral proteins inEscherichia coli as the membrane-associated proteins OmpL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
105
0
23

Year Published

2001
2001
2014
2014

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 226 publications
(136 citation statements)
references
References 47 publications
4
105
0
23
Order By: Relevance
“…Hence, in this study no vaccine synergy was noted when an outer membrane lipoprotein (LipL32/ Hap-1) and a transmembrane OMP (OmpL1) were administered together. This lends credence to the hypothesis that the synergy observed in the study by Haake et al [185], was a result of a specific interaction between LipL41 and OmpL1. However, the adenovirus-encoded LipL32/Hap-1 and OmpL1 would undoubtedly not contain the post-translational lipid modification and any conformational epitopes, which are likely to be associated with the membrane forms of these proteins, and which were found to be critical for immunoprotection in the study performed by Haake et al [185].…”
Section: Leptospiral Lipl32/hap-1supporting
confidence: 81%
See 1 more Smart Citation
“…Hence, in this study no vaccine synergy was noted when an outer membrane lipoprotein (LipL32/ Hap-1) and a transmembrane OMP (OmpL1) were administered together. This lends credence to the hypothesis that the synergy observed in the study by Haake et al [185], was a result of a specific interaction between LipL41 and OmpL1. However, the adenovirus-encoded LipL32/Hap-1 and OmpL1 would undoubtedly not contain the post-translational lipid modification and any conformational epitopes, which are likely to be associated with the membrane forms of these proteins, and which were found to be critical for immunoprotection in the study performed by Haake et al [185].…”
Section: Leptospiral Lipl32/hap-1supporting
confidence: 81%
“…Co-administration of the surface-exposed leptospiral OMPs OmpL1 and LipL41 was shown to mediate partial synergistic immunoprotection in the hamster model of leptospirosis [185]. In contrast to the vaccine synergism observed between OspA and DbpA [241], neither leptospiral antigen alone was able to elicit protective immunity.…”
Section: Ompl1/lipl41 Leptospiral Surface Proteinsmentioning
confidence: 95%
“…This result suggests that leptospiral protein(s) can be candidates for a new vaccine that prevents infection with a broad spectrum of Leptospira . Some outer membrane proteins of Leptospira , lipoproteins LipL32 (also known as Hap1), LipL41 and the porin OmpL1, have been found to be protective immunogens that are conserved among various pathogenic leptospires [3–7].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, leptospiral LPS elicits the production of agglutinating, opsonic, protective antibodies in mice, hamsters and humans [2^4]. Even though a protective role for OmpL1 and LipL41 outer membrane proteins in leptospirosis has been reported [5], LPS is considered the main protective antigen identi¢ed thus far in leptospires [6]. There are no data describing the structure of the LPS of Leptospira that would explain the serological diversity in this species.…”
Section: Introductionmentioning
confidence: 99%